Crossmark

Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies

Published Online: 2023-03-13

Published Print: 2023-05

Authors

Thorlacius, Gudny Ella

Björk, Albin

Wahren-Herlenius, Marie https://orcid.org/0000-0002-0915-7245
License Information

Text and Data Mining valid from 2023-03-13

Version of Record valid from 2023-03-13
More Information

Article History

Accepted: 13 February 2023

First Online: 13 March 2023

Competing interests

: M.W.-H. has received research grants from Merck KGaA and Janssen Pharmaceutica NV during the past 5 years. G.E.T. and A.B. declare no competing interests.

Document is current